That might include hormone health, longevity goals, or gentle weight loss
Additional risk factors commonly present in patients prescribed GLP-1 receptor agonists include: Reduced physical activity and prolonged immobility Hypertension and other cardiovascular comorbidities Dyslipidaemia contributing to atherosclerosis Advanced age , as thrombotic risk increases with ageing Other important VTE risk factors include: Previous VTE or family history of clotting disorders Thrombophilia (inherited or acquired clotting disorders) Active cancer or cancer treatment Oestrogen-containing medications (HRT, combined oral contraceptives) Pregnancy and postpartum period Recent surgery, trauma or hospitalisation Long-haul travel with prolonged immobility Smoking When patients taking GLP-1 receptor agonists experience thrombotic events, it is important to consider these pre-existing risk factors as they often contribute significantly to clotting risk in this population
Amazon.com: Peptide Power: A Practical Guide to Enhancing Muscle Strength, Recovery, and Athletic Performance: BPC-157, TB-500 and Other Peptides for Optimal Performance eBook : Plantagenet, Grant: Kindle Store
Order online today and enjoy competitive pricing and reliable service
Patients with delayed improvement should be offered rehabilitative therapy, particularly for gait, urinary, or bowel dysfunction
